Company Overview and News

14
North American Financial 15 Split Corp. Regular Monthly Dividend Declaration for Class A & Preferred Share

2018-07-18 globenewswire
TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- North American Financial 15 Split Corp. (The "Company") declares its regular monthly distribution of $0.10000 for each Class A share ($1.20 annually) and $0.04583 for each Preferred share ($0.550 annually). Distributions are payable August 10, 2018 to shareholders on record as at July 31, 2018.
MFC.PR.B C.WSA MFC.PR.F MFC.PR.C GS.PRB GS.PRA CIFAF GLSSP GWO JBK TFG GS.PRJ GS.PRI MFC 0945 GS.PRD CGBBW GS.PRC CIX SLFYF GS.PRN GWLIF SLF GS.PRK WFCNP FFN NAF.UN SLF WFC.PRL WFC.PRJ TD WFC.PRT GS C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP SLF.PR.G C.PRU WFC.PRY WFC.PRX TD SLF.PR.B WFC.PRW SLF.PR.E WFC.PRV C.PRS SLF.PR.D WFC WFC.WS TNTTF C.PRL C GSC GS.PRICL C.PRJ C.PRK C.PRG GSJ C.PRC SLF GWLOF C.PRPCL MFC.PR.I MFC.PR.J GWO.PR.I MFC GWO.PR.H MFC.PR.H GJS MFC.PR.M GWO.PR.F MFC.PR.N MFC.PR.K MFC.PR.L

0
M Split Corp. - Monthly Dividend Declared for Class I Preferred Shares

2018-07-18 globenewswire
TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- M Split Corp. ("M Split") declares its monthly distribution of $0.03125 per share ($0.375 annually) for Class I Preferred shareholders. The Class I Preferred share dividends are paid at an annual rate of 7.50% based on the $5 notional issue price. Distributions are payable August 10, 2018 to shareholders on record as at July 31, 2018.
MFC.PR.B MFC.PR.F MFC.PR.C MFC 0945 MFC.PR.I MFC.PR.J MFC MFC.PR.H MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L

1
Dividend 15 Split Corp. II: Regular Monthly Dividend Declaration for Class A & Preferred Share

2018-07-18 globenewswire
TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- Dividend 15 Split Corp. II ("Dividend 15 II") declares its regular monthly distribution of $0.10000 for each Class A share and $0.04375 for each Preferred share. Distributions are payable August 10, 2018 to shareholders on record as at July 31, 2018.
MFC.PR.B SLF MFC.PR.F MFC.PR.C TAC CIFAF TD BCE SLF.PR.G SLF.PR.B TD SLF.PR.E SLF.PR.D TRP TNTTF DF SLF MFC 0945 MFC.PR.I CIX TRI MFC.PR.J MFC MFC.PR.H SLFYF MFC.PR.M MFC.PR.N MFC.PR.K TU MFC.PR.L SLF

14
Financial 15 Split Corp. Regular Monthly Dividend Declaration for Class A & Preferred Share

2018-07-18 globenewswire
TORONTO, July 18, 2018 (GLOBE NEWSWIRE) -- Financial 15 Split Corp. ("Financial 15") declares its regular monthly distribution of $0.12570 for each Class A share ($1.51 annually) and $0.04583 for each Preferred share ($0.550 annually). Distributions are payable August 10, 2018 to shareholders on record as at July 31, 2018.
MFC.PR.B C.WSA MFC.PR.F MFC.PR.C GS.PRB GS.PRA CIFAF GLSSP GWO JBK TFG GS.PRJ GS.PRI MFC 0945 GS.PRD CGBBW GS.PRC CIX SLFYF GS.PRN GWLIF SLF GS.PRK WFCNP SLF WFC.PRL WFC.PRJ TD WFC.PRT GS C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP SLF.PR.G C.PRU WFC.PRY WFC.PRX TD SLF.PR.B WFC.PRW SLF.PR.E WFC.PRV C.PRS SLF.PR.D WFC WFC.WS TNTTF C.PRL C GSC GS.PRICL C.PRJ C.PRK C.PRG GSJ C.PRC SLF GWLOF C.PRPCL MFC.PR.I MFC.PR.J GWO.PR.I MFC GWO.PR.H MFC.PR.H GJS MFC.PR.M GWO.PR.F MFC.PR.N MFC.PR.K MFC.PR.L

0
Why Canadian insurers are wary of covering medical marijuana - Channel NewsAsia

2018-07-13 channelnewsasia
Sun Life Financial, Canada's No. 2 insurer, recently started covering medical marijuana in its Canadian health insurance plan - more than 17 years after the country first legalized it.
MFC.PR.B SLF MFC.PR.F MFC.PR.C SLF MFC 0945 NACNF MFC.PR.I SLF.PR.G MFC.PR.J MFC SLFYF MFC.PR.H MFC.PR.M SLF.PR.B MFC.PR.N SLF.PR.E MFC.PR.K SLF.PR.D MFC.PR.L SLF

0
Why Canadian insurers are wary of covering medical marijuana

2018-07-13 reuters
TORONTO, July 13 (Reuters) - Sun Life Financial, Canada’s No. 2 insurer, recently started covering medical marijuana in its Canadian health insurance plan - more than 17 years after the country first legalized it.
MFC.PR.B SLF MFC.PR.F MFC.PR.C SLF MFC 0945 NACNF MFC.PR.I SLF.PR.G MFC.PR.J MFC SLFYF MFC.PR.H MFC.PR.M SLF.PR.B MFC.PR.N SLF.PR.E MFC.PR.K SLF.PR.D MFC.PR.L SLF

1
MaRS tech hub hunts for second Toronto office as firms clamour for space

2018-07-10 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
MFC.PR.B SHOP SLF MFC.PR.F MFC.PR.C SLF MFC 0945 MFC.PR.I SLF.PR.G MFC.PR.J MFC MSFT MFC.PR.H SLFYF MFC.PR.M SLF.PR.B MFC.PR.N SLF.PR.E MFC.PR.K SLF.PR.D MFC.PR.L SLF

0
PRESS DIGEST- Canada- July 3

2018-07-03 reuters
July 3 (Reuters) - The following are the top stories from select Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
MFC.PR.B MFC.PR.F MFC.PR.C MFC 0945 MFC.PR.I MFC.PR.J MFC MFC.PR.H MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L

24
Dividend Champions For July 2018

2018-07-02 seekingalpha
The Dividend Champions list is a monthly publication tracking companies with a history of consistently increasing their dividends. Wider in scope than the well-known S&P 500 Dividend Aristocrats and Nasdaq Dividend Achievers, the Dividend Champions covers all companies listed on exchanges in the United States. In order to be included in the list, the annual split-adjusted dividend payout of a company (based on calendar year) must be consistently increasing.
MFC.PR.B CQP MFC.PR.F MFC.PR.C TKR FITBI WMS CTRE REXR.PRB FISI REXR.PRA WEBK FIISO FIISP MDLZ MFC 0945 OLBK PRIM TTEK MFC.PR.I MFC.PR.J REXR MFC FITB MFC.PR.H MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L

18
Energy and pot stocks help TSX to best quarter in 4 years

2018-06-29 reuters
TORONTO, June 29 (Reuters) - Canada’s main stock index notched its biggest quarterly gain in more than four years and could gain more this year as higher oil prices boost energy shares and legalization of pot leads to deal making among cannabis companies, investors said.
MFC.PR.B MFC.PR.F MFC.PR.C SU MFC 0945 CNQ MFC.PR.I MFC.PR.J MFC MFC.PR.H MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L SU

5
PRESS DIGEST - Canada - June 22

2018-06-22 reuters
June 22 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.
MFC.PR.B MFC.PR.F MFC.PR.C MFC 0945 MFC.PR.I MFC.PR.J MFC LB MFC.PR.H MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L

30
Vietcombank said to tap Credit Suisse to find insurance partner

2018-06-22 theedgemarkets
SINGAPORE/HANOI (June 22): Bank for Foreign Trade of Vietnam JSC, the nation’s biggest listed lender by market value, appointed Credit Suisse Group AG to advise on finding a new insurance distribution partner, people with knowledge of the matter said.
MFC.PR.B MFC.PR.F DGLD MFC.PR.C BNPQY CS UGLD D05 DBSDF DSLV DBSDY VIIX CSSLF VIIZ BNPQF BNPZY CSGKF MFC 0945 MFC.PR.I MFC.PR.J ZIV USLV MFC MFC.PR.H TVIX 8750 MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L XIV

5
UPDATE 1-Manulife to cut 5 pct of Canadian workforce in technology push

2018-06-21 reuters
June 21 (Reuters) - Canada’s Manulife Financial Corp is cutting some 700 jobs in the country as part of a drive to automate certain functions, the insurer said on Thursday.
MFC.PR.B MFC.PR.F MFC.PR.C MFC 0945 MFC.PR.I MFC.PR.J MFC MFC.PR.H MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L

5
Manulife cutting 700 jobs as it restructures operations

2018-06-21 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
MFC.PR.B MFC.PR.F MFC.PR.C MFC 0945 MFC.PR.I MFC.PR.J MFC MFC.PR.H MFC.PR.M MFC.PR.N MFC.PR.K MFC.PR.L

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...